Tu1577 MORTALITY IN PATIENTS TREATED WITH TRANSARTERIAL RADIOEMBOLIZATION (TARE) OR SBRT FOR HEPATOCELLULAR CARCINOMA (HCC)
Leggi →
Maggio 2024
Risultati per: Gestione del carcinoma polmonare (cancro al polmone) non a piccole cellule
Questo è quello che abbiamo trovato per te
Tu1137 ESOPHAGEAL AND GASTRIC CARDIA PRECURSOR LESIONS AND RISK OF ESOPHAGEAL SQUAMOUS CELL CARCINOMA AND GASTRIC CARDIA ADENOCARCINOMA IN POPULATION-BASED, PROSPECTIVE COHORTS IN CHINA
Leggi →
Maggio 2024
Tu1569 PREVALENCE OF SARCOPENIA AND ITS RELATED FACTORS AMONG PATIENTS WITH HEPATOCELLULAR CARCINOMA: A META-ANALYSIS
Leggi →
Maggio 2024
Tu1568 COMPARATIVE ANALYSIS OF THE SAFETY OF NON-TRANSPLANT TREATMENT OPTIONS FOR EARLY- TO INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA ACROSS A LARGE, INTEGRATED HEALTH CARE SYSTEM IN NORTHERN CALIFORNIA.
Leggi →
Maggio 2024
Tu1565 ENHANCEMENT PATTERN MAPPING FOR EARLY DETECTION OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CIRRHOSIS
Leggi →
Maggio 2024
Tu1564 SINGLE-CENTER STUDY ON SEX DISPARITIES IN RISK FACTORS FOR HEPATOCELLULAR CARCINOMA
Leggi →
Maggio 2024
Tu1584 INTRATUMORAL IMMUNE MODULATION FOR HEPATOCELLULAR CARCINOMA
Leggi →
Maggio 2024
Tu1536 RISK OF CANCER RECURRENCE AND OVERALL SURVIVAL OF PATIENTS WITH CHRONIC HEPATITIS B AND/OR HEPATIC STEATOSIS AFTER SURGICAL RESECTION FOR HEPATOCELLULAR CARCINOMA
Leggi →
Maggio 2024
Tu1549 INTRATUMORAL SALMONELLA ABUNDANCE IN HEPATOCELLULAR CARCINOMA IS ASSOCIATED WITH INCREASED DENDRITIC CELL INFILTRATE AND IMPROVED SURVIVAL OUTCOMES
Leggi →
Maggio 2024
Tu1553 RACIAL AND SOCIOECONOMIC DIFFERENCES IN INTENSITY OF ENDOF-LIFE CARE AMONG TERMINAL HEPATOCELLULAR CARCINOMA PATIENTS
Leggi →
Maggio 2024
Tu1552 RIBOSOMAL PROTEINS RPS8 AND RPLP0 PROMOTE HEPATOCELLULAR CARCINOMA METASTASIS
Leggi →
Maggio 2024
Tu1540 SOCIODEMOGRAPHIC FACTORS EXACERBATE EXISTING DISPARITIES IN TUMOR STAGE AT DIAGNOSIS AMONG ETHNIC MINORITIES WITH HEPATOCELLULAR CARCINOMA
Leggi →
Maggio 2024
Tu1541 UPREGULATION OF ANDROGEN RECEPTOR TRANSCRIPTIONAL ACTIVITY IN A-FETOPROTEIN-NEGATIVE HEPATOCELLULAR CARCINOMA PROMOTES ARACHIDONIC ACID METABOLISM AND FORMATION OF ANGIOGENESIS MICROENVIRONMENT
Leggi →
Maggio 2024
Tu1548 BARRIERS TO HEPATOCELLULAR CARCINOMA SCREENING IN PATIENTS WITH MEDICAID INSURANCE: A PATIENT SURVEY
Leggi →
Maggio 2024
Tu1544 CLINICAL BENEFITS OF HEPATOCELLULAR CARCINOMA SURVEILLANCE IN A CONTEMPORARY COHORT OF AT-RISK PATIENTS
Leggi →
Maggio 2024
Tu1545 CLINICAL SIGNIFICANCE OF SERUM C-REACTIVE PROTEIN LEVELS FOR PREDICTING LENVATINIB-TREATED UNRESECTABLE HEPATOCELLULAR CARCINOMA: A MULTI-INSTITUTIONAL STUDY IN JAPAN
Leggi →
Maggio 2024
